propidium has been researched along with methotrexate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, N; Bruce-Gregorios, JH; Chen, MG; Soucy, D | 1 |
| Goldfinger, N; Lilling, G; Nordenberg, J; Peller, S; Rotter, V; Sidi, Y | 1 |
| Deutsch, M; Herman, S; Zurgil, N | 1 |
| Choi, G; Choy, JH; Kwon, OJ; Oh, Y; Yun, CO | 1 |
4 other study(ies) available for propidium and methotrexate
| Article | Year |
|---|---|
Effect of methotrexate on cell cycle and DNA synthesis of astrocytes in primary culture: flow cytometric studies.
Topics: Animals; Astrocytes; Bromodeoxyuridine; Cell Cycle; Cells, Cultured; DNA; Flow Cytometry; Methotrexate; Propidium | 1991 |
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Survival; DNA Primers; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Immunoenzyme Techniques; Methotrexate; Neoplasms, Hormone-Dependent; Propidium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Subcellular Fractions; Tamoxifen; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines.
Topics: Acetylcysteine; Annexin A5; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Arthritis, Rheumatoid; Biological Assay; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Immunosuppressive Agents; Jurkat Cells; Leukocytes; Methotrexate; Monocytes; Oxidative Stress; Propidium; Reactive Oxygen Species; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Time Factors; U937 Cells | 2005 |
Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
Topics: Aluminum Silicates; Animals; Annexin A5; Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Compounding; Female; Half-Life; Heterografts; Humans; Liver; Magnesium Hydroxide; Mammary Glands, Animal; Methotrexate; Mice; Neoplasm Transplantation; Particle Size; Propidium; Tumor Burden | 2014 |